서브이미지

IR/PR

PR Center

FDA Issues a GRAS No Objections Letter for GenoFocus' Lactase

페이지 정보

작성자 관리자 작성일22-01-24 11:36 조회884회 댓글0건

본문

FDA Issues a GRAS No Objections Letter for GenoFocus' Lactase 


GenoFocus is pleased to announce that the FDA has issued a GRAS no objections letter for GenoFocus' Lactase, demonstrating our enzyme's safety.